HBK Sorce Advisory LLC - NRX PHARMACEUTICALS INC ownership

NRX PHARMACEUTICALS INC's ticker is NRXP and the CUSIP is 629444100. A total of 36 filers reported holding NRX PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.

Quarter-by-quarter ownership
HBK Sorce Advisory LLC ownership history of NRX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$7,600
-46.2%
29,2300.0%0.00%
-100.0%
Q2 2023$14,133
-26.6%
29,2300.0%0.00%0.0%
Q1 2023$19,266
+29540.0%
29,230
-50.0%
0.00%
-50.0%
Q4 2022$6558,4600.00%
Other shareholders
NRX PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Texas Capital Bank Wealth Management Services Inc 63,290$41,7140.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 230,700$152,0540.00%
Virtu Financial LLC 46,210$300.00%
United Asset Strategies, Inc. 18,300$12,0620.00%
HBK Sorce Advisory LLC 29,230$19,2660.00%
UBS Group AG 18,611$12,2650.00%
NewEdge Advisors, LLC 2,125$1,4010.00%
OSAIC HOLDINGS, INC. 27,225$17,9330.00%
BANK OF AMERICA CORP /DE/ 30,000$19,7700.00%
WELLS FARGO & COMPANY/MN 5,309$3,5000.00%
View complete list of NRX PHARMACEUTICALS INC shareholders